Related Experiment Video
Updated: Jan 30, 2026

Visualizing and Tracking Endogenous mRNAs in Live Drosophila melanogaster Egg Chambers
Published on: June 4, 2019
Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma
Kun-Peng Zhu1, Chun-Lin Zhang1, Xiao-Long Ma1
1Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, PR China; Institute of Bone Tumor, Tongji University, School of Medicine, Shanghai 200072, PR China.
Abstract:
Chemo-resistance is a huge obstacle encountered in the osteosarcoma (OS) treatment. Protein-coding mRNAs, as well as non-coding RNAs (ncRNAs), including long ncRNA (lncRNA), circular RNA (circRNA), and microRNA (miRNA), have been demonstrated to play an essential role in the regulation of cancer biology. However, the comprehensive expression profile and competing endogenous RNA (ceRNA) regulatory network between mRNAs and ncRNAs in the OS chemo-resistance still remain unclear. In the current study, we developed whole-transcriptome sequencing (RNA sequencing [RNA-seq]) in the three paired multi-drug chemo-resistant and chemo-sensitive OS cell lines to comprehensively identify differentially expressed lncRNAs, circRNAs, miRNAs, and mRNAs. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed for mRNAs with significantly different expression. Then the ceRNA networks combining lncRNAs, circRNAs, miRNAs, and mRNAs were predicted and constructed on the basis of the authoritative miRanda and TargetScan databases combined with the widely accepted vital drug resistance-related genes and signal transduction pathways. In addition, two constructed ceRNA regulatory pathways, lncRNAMEG3/hsa-miR-200b-3p/AKT2 and hsa_circ_0001258/hsa-miR-744-3p/GSTM2, were randomly selected and validated by real-time qPCR, RNA immunoprecipitation (RIP), RNA pull-down assay, and dual luciferase reporter gene system. Taken together, our findings may provide new evidence for the underlying mechanism of OS chemo-resistance and uncover some novel targets for reversing it.
Insights
Chemo-resistance in osteosarcoma (OS) is a major challenge. This study identifies novel competing RNA networks (ceRNAs) involving long non-coding RNAs, circular RNAs, and messenger RNAs, offering potential targets to overcome drug resistance in OS.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Chemo-resistance significantly hinders osteosarcoma (OS) treatment outcomes.
- Both protein-coding messenger RNAs (mRNAs) and non-coding RNAs (ncRNAs) regulate cancer biology, but their roles in OS chemo-resistance are not fully understood.
- The comprehensive expression profiles and competing endogenous RNA (ceRNA) regulatory networks in chemo-resistant OS remain largely unelucidated.
Purpose of the Study:
- To comprehensively identify differentially expressed long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), microRNAs (miRNAs), and mRNAs in chemo-resistant versus chemo-sensitive osteosarcoma (OS) cell lines.
- To construct and analyze the competing endogenous RNA (ceRNA) regulatory network underlying OS chemo-resistance.
- To identify potential novel therapeutic targets for reversing chemo-resistance in osteosarcoma.
Main Methods:
- Whole-transcriptome RNA sequencing (RNA-seq) was performed on paired chemo-resistant and chemo-sensitive OS cell lines.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted on differentially expressed mRNAs.
- ceRNA networks were predicted using miRanda and TargetScan databases, integrating drug resistance-related genes and pathways. Validation involved real-time qPCR, RNA immunoprecipitation (RIP), RNA pull-down, and dual luciferase reporter assays.
Main Results:
- Identification of differentially expressed lncRNAs, circRNAs, miRNAs, and mRNAs between chemo-resistant and chemo-sensitive OS cells.
- Construction of comprehensive ceRNA networks, revealing complex regulatory interactions.
- Validation of two specific ceRNA pathways (lncRNAMEG3/hsa-miR-200b-3p/AKT2 and hsa_circ_0001258/hsa-miR-744-3p/GSTM2) providing mechanistic insights.
Conclusions:
- The study elucidates the complex molecular landscape of chemo-resistance in osteosarcoma through comprehensive transcriptomic analysis.
- Identified ceRNA networks offer novel insights into the mechanisms driving drug resistance in OS.
- The findings suggest potential therapeutic targets for overcoming chemo-resistance and improving osteosarcoma treatment outcomes.
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
RNA Polymerase II Accessory Proteins
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Predicting Molecular Geometry
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.

